Skip to main content

Advertisement

Log in

Aberrant methylation and loss expression of RKIP is associated with tumor progression and poor prognosis in gastric cardia adenocarcinoma

  • Research Paper
  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Raf kinase inhibitory protein (RKIP) has been identified as a member of a novel class of molecules which implicated in cancer progression and suppress the metastatic spread of tumors. The aim of this study was to investigate the promoter methylation and expression of RKIP, determine the prognostic significance of RKIP in gastric cardia adenocarcinoma (GCA). MSP approach and immunohistochemistry methods were used respectively to examine methylation status and protein expression of RKIP in GCA tissues. The frequency of RKIP methylation in GCA tumor tissues (62.1 %) was significantly higher than that in corresponding normal tissues (4.1 %) and was associated with TNM stage, histological differentiation, depth of invasion, LN metastasis, distant metastasis or recurrence, and upper gastrointestinal cancers (UGIC) family history. Positive staining of RKIP in GCA tumor tissues (34.5 %) was significantly decreased than that in corresponding normal tissues (84.1 %) and was associated with RKIP methylation. RKIP may act as a tumor suppressor gene in GCA by regulation of the Raf-1/MEK/ERK signaling pathway. GCA patients in stage III and IV, with positive UGIC family history, and hypermethylation and down-expression of RKIP were most likely to develop metastatic disease and also showed the worse survival. RKIP methylation in GCA was an independent prognostic marker for survival using multivariate Cox regression analysis (P = 0.04). In all, aberrant hypermethylation of RKIP may be one of the mechanisms that lead to loss or down expression of the gene in GCA especially in individuals with UGIC family history. Additionally, hypermethylation and loss of RKIP expression may be used as a marker to predict clinical outcome of GCA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bernier I, Tresca JP, Jollès P (1986) Ligand-binding studies with a 23 kDa protein purified from bovine brain cytosol. Biochim Biophys Acta 871:19–23

    Article  PubMed  CAS  Google Scholar 

  2. Serre L, Pereira de Jesus K, Zelwer C, Bureaud N, Schoentgen F, Bénédetti H (2001) Crystal structures of YBHB and YBCL from Escherichia coli, two bacterial homologues to a Raf kinase inhibitor protein. J Mol Biol 310:617–634

    Article  PubMed  CAS  Google Scholar 

  3. Schoentgen F, Jollès P (1995) From structure to function: possible biological roles of a new widespread protein family binding hydrophobic ligands and displaying a nucleotide binding site. FEBS Lett 369:22–26

    Article  PubMed  CAS  Google Scholar 

  4. Trakul N, Rosner MR (2005) Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein. Cell Res 15:19–23

    Article  PubMed  CAS  Google Scholar 

  5. Yeung K, Seitz T, Li S, Janosch P, McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H, Sedivy JM, Kolch W (1999) Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401:173–177

    Article  PubMed  CAS  Google Scholar 

  6. Trakul N, Menard RE, Schade GR, Qian Z, Rosner MR (2005) Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation. J Biol Chem 280:24931–24940

    Article  PubMed  CAS  Google Scholar 

  7. Corbit KC, Trakul N, Eves EM, Diaz B, Marshall M, Rosner MR (2003) Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J Biol Chem 278:13061–13068

    Article  PubMed  CAS  Google Scholar 

  8. Lorenz K, Lohse MJ, Quitterer U (2003) Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 426:574–579

    Article  PubMed  CAS  Google Scholar 

  9. Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, Yao Z, Keller ET (2003) Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 95:878–889

    Article  PubMed  CAS  Google Scholar 

  10. Schuierer MM, Bataille F, Hagan S, Kolch W, Bosserhoff AK (2004) Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res 64:5186–5192

    Article  PubMed  CAS  Google Scholar 

  11. Hagan S, Al-Mulla F, Mallon E, Oien K, Ferrier R, Gusterson B, Garcia JJ, Kolch W (2005) Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 11:7392–7397

    Article  PubMed  CAS  Google Scholar 

  12. Zhang L, Fu Z, Binkley C, Giordano T, Burant CF, Logsdon CD, Simeone DM (2004) Raf kinase inhibitory protein inhibits beta-cell proliferation. Surgery 136:708–715

    Article  PubMed  Google Scholar 

  13. Minoo P, Zlobec I, Baker K, Tornillo L, Terracciano L, Jass JR, Lugli A (2007) Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer. Am J Clin Pathol 127:820–827

    Article  PubMed  Google Scholar 

  14. Zlobec I, Baker K, Minoo P, Jass JR, Terracciano L, Lugli A (2008) Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression. Clin Cancer Res 14:143–148

    Article  PubMed  CAS  Google Scholar 

  15. Chatterjee D, Sabo E, Tavares R, Resnick MB (2008) Inverse association between Raf kinase inhibitory protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome. Clin Cancer Res 14:2994–3001

    Article  PubMed  CAS  Google Scholar 

  16. Huerta-Yepez S, Yoon NK, Hernandez-Cueto A, Mah V, Rivera-Pazos CM, Chatterjee D, Vega MI, Maresh EL, Horvath S, Chia D, Bonavida B, Goodglick L (2011) Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival. BMC Cancer 11:259

    Article  PubMed  Google Scholar 

  17. Schuierer MM, Bataille F, Weiss TS, Hellerbrand C, Bosserhoff AK (2006) Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. Oncol Rep 16:451–456

    PubMed  CAS  Google Scholar 

  18. Al-Mulla F, Hagan S, Behbehani AI, Bitar MS, George SS, Going JJ, García JJ, Scott L, Fyfe N, Murray GI, Kolch W (2006) Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol 24:5672–5679

    Article  PubMed  CAS  Google Scholar 

  19. Al-Mulla F, Hagan S, Al-Ali W, Jacob SP, Behbehani AI, Bitar MS, Dallol A, Kolch W (2008) Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability. J Clin Pathol 61:524–529

    Article  PubMed  CAS  Google Scholar 

  20. Yang L (2006) Incidence and mortality of gastric cancer in China. World J Gastroenterol 12:17–20

    PubMed  Google Scholar 

  21. Ma JL, Zhang L, Brown LM, Li JY, Shen L, Pan KF, Liu WD, Hu Y, Han ZX, Crystal-Mansour S, Pee D, Blot WJ, Fraumeni JF Jr, You WC, Gail MH (2012) Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst 104:488–492

    Article  PubMed  CAS  Google Scholar 

  22. Li JY, Ershow AG, Chen ZJ, Wacholder S, Li GY, Guo W, Li B, Blot WJ (1989) A case-control study of cancer of the esophageal and gastric cardia in Linxian. Int J Cancer 43:755–761

    Article  PubMed  CAS  Google Scholar 

  23. Yang CS (2000) Vitamin nutrition and gastroesophageal cancer. J Nutr 130:338S–339S

    PubMed  CAS  Google Scholar 

  24. Yokokawa Y, Ohta S, Hou J, Zhang XL, Li SS, Ping YM, Nakajima T (1999) Ecological study on the risks of esophageal cancer in Ci-Xian, China: the importance of nutritional status and the use of well water. Int J Cancer 83:620–624

    Article  PubMed  CAS  Google Scholar 

  25. Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85:1457–1459

    Article  PubMed  CAS  Google Scholar 

  26. Guo W, Dong Z, Chen Z, Yang Z, Wen D, Kuang G, Guo Y, Shan B (2009) Aberrant CpG island hypermethylation of RASSF1A in gastric cardia adenocarcinoma. Cancer Investig 27:459–465

    Article  CAS  Google Scholar 

  27. Umemoto M, Yokoyama Y, Sato S, Tsuchida S, Al-Mulla F, Saito Y (2001) Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer. Br J Cancer 85:1032–1036

    Article  PubMed  CAS  Google Scholar 

  28. Minoo P, Baker K, Goswami R, Chong G, Foulkes WD, Ruszkiewicz AR, Barker M, Buchanan D, Young J, Jass JR (2006) Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 55:1467–1474

    Article  PubMed  CAS  Google Scholar 

  29. Martinho O, Gouveia A, Silva P, Pimenta A, Reis RM, Lopes JM (2009) Loss of RKIP expression is associated with poor survival in GISTs. Virchows Arch 455:277–284

    Article  PubMed  CAS  Google Scholar 

  30. Wang J, Yang YH, Wang AQ, Yao B, Xie G, Feng G, Zhang Y, Cheng ZS, Hui L, Dai TZ, Du XB, Wang D (2010) Immunohistochemical detection of the Raf kinase inhibitor protein in nonneoplastic gastric tissue and gastric cancer tissue. Med Oncol 27:219–223

    Article  PubMed  Google Scholar 

  31. Fujimori Y, Inokuchi M, Takagi Y, Kato K, Kojima K, Sugihara K (2012) Prognostic value of RKIP and p-ERK in gastric cancer. J Exp Clin Cancer Res 31:30

    Article  PubMed  CAS  Google Scholar 

  32. Lugli A, Zlobec I, Minoo P, Baker K, Tornillo L, Terracciano L, Jass JR (2006) Role of the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways downstream molecules, phosphorylated extracellular signal-regulated kinase, and phosphorylated AKT in colorectal cancer-a tissue microarray-based approach. Hum Pathol 37:1022–1031

    Article  PubMed  CAS  Google Scholar 

  33. Guo W, Dong Z, Guo Y, Chen Z, Kuang G, Yang Z (2011) Aberrant methylation of the CpG island of HLTF gene in gastric cardia adenocarcinoma and dysplasia. Clin Biochem 44:784–788

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank the patients and control individuals for taking part in this study. Supported by grants from the National Natural Science Foundation (No. 81101854).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhiming Dong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guo, W., Dong, Z., Guo, Y. et al. Aberrant methylation and loss expression of RKIP is associated with tumor progression and poor prognosis in gastric cardia adenocarcinoma. Clin Exp Metastasis 30, 265–275 (2013). https://doi.org/10.1007/s10585-012-9533-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10585-012-9533-x

Keywords

Navigation